Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00199069
Status:
COMPLETED
Last Update Posted:
2023-03-17
First Post:
2005-09-12
Brief Title:
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults 0593
Sponsor:
Goethe University
Organization:
Goethe University
Study Overview
Official Title:
Multicenter Trial for Treatment of Acute Lymphoblastic Leukemia in Adults 0593
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study evaluates the efficacy and tolerability of a risk- and subtype-adapted chemotherapy over one year followed by randomized either intensified or conventional maintenance therapy It includes a distinct protocol for the subgroup mature B-ALL
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None